Unveiling gut microbes' influence on cancer patient response to immunotherapy

November 02, 2017

Two new studies in cancer patients demonstrate how the composition of gut bacteria can influence response to immunotherapy. Antibiotics, one study showed, render such treatments less effective. And "good bacteria" are more abundant in patients who respond well to immunotherapy, the second study reports. Together, these studies suggest that maintaining healthy gut flora could help combat cancer. First, Bertrand Routy and colleagues explored how antibiotics might influence the outcomes of patients with lung or kidney cancer undergoing immunotherapy with PD-1 inhibitors, a type of therapy that activates the immune system to attack tumors. Patients who had previously taken antibiotics (for urinary or dental infections, for example) had reduced survival compared to those who were not on antibiotics. Analysis of patients' gut microbes revealed that an abundance of the bacterium Akkermansia muciniphila was associated with the best clinical outcome. The species was detectable in 69% and 58% of patients exhibiting a partial response or stable disease respectively, but only detectable in 34% of patients who did not respond to therapy. In mice treated with antibiotics, oral supplementation of the bacteria increased the efficacy of the mice's immune cells, boosting their response to therapy, the authors report.

In the second study, Vancheswaran Gopalakrishnan et al. report that melanoma patients who respond better to the same PD-1 inhibitors have greater gut microbe diversity and abundance of certain bacteria. They collected and analyzed microbiome samples from 112 patients with advanced melanoma who were also taking PD-1 inhibitors. Patients whose microbiomes were enriched with the bacteria Faecalibacterium and Clostridiales were more likely to respond to treatment and to experience longer, progression-free survival, while the opposite was found for patients whose microbiomes were more enriched with Bacteroidales bacteria. Analysis of patients' immune responses revealed that those with the beneficial microbes tended to have more immune cells, which may be more likely to infiltrate and kill tumors. Transplanting the microbes from responding patients into germ-free mice and monitoring their response to PD-1 inhibitors yielded similar results to what was observed in humans, the authors report. Together, the results of the two studies hold important implications for the treatment of cancer patients with immune checkpoint inhibitors.
-end-


American Association for the Advancement of Science

Related Bacteria Articles from Brightsurf:

Siblings can also differ from one another in bacteria
A research team from the University of Tübingen and the German Center for Infection Research (DZIF) is investigating how pathogens influence the immune response of their host with genetic variation.

How bacteria fertilize soya
Soya and clover have their very own fertiliser factories in their roots, where bacteria manufacture ammonium, which is crucial for plant growth.

Bacteria might help other bacteria to tolerate antibiotics better
A new paper by the Dynamical Systems Biology lab at UPF shows that the response by bacteria to antibiotics may depend on other species of bacteria they live with, in such a way that some bacteria may make others more tolerant to antibiotics.

Two-faced bacteria
The gut microbiome, which is a collection of numerous beneficial bacteria species, is key to our overall well-being and good health.

Microcensus in bacteria
Bacillus subtilis can determine proportions of different groups within a mixed population.

Right beneath the skin we all have the same bacteria
In the dermis skin layer, the same bacteria are found across age and gender.

Bacteria must be 'stressed out' to divide
Bacterial cell division is controlled by both enzymatic activity and mechanical forces, which work together to control its timing and location, a new study from EPFL finds.

How bees live with bacteria
More than 90 percent of all bee species are not organized in colonies, but fight their way through life alone.

The bacteria building your baby
Australian researchers have laid to rest a longstanding controversy: is the womb sterile?

Hopping bacteria
Scientists have long known that key models of bacterial movement in real-world conditions are flawed.

Read More: Bacteria News and Bacteria Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.